UNC Health Pardee says it's the first health care organization in Western North Carolina to administer a newly FDA-approved drug to treat Alzheimer's disease.
A single course of treatment with an Alzheimer's drug developed by Japanese company Eisai Co. and U.S. firm Biogen Inc. will cost around 2.98 million ($20,500) per year in Japan and will be largely covered by public health insurance, a health ministry body says.
UAB is looking to enroll people into a new Alzheimer's study. It's called the AHEAD study.Recently, the food and drug administration approved a new alzheimer’s